Page 14 - HFA Dateline 2020-2021 Special Issue

For the treatment of bleeding episodes in people with hemophilia A or B with inhibitors
*
I’M READY TO MOVE ON

Get rapid, predictable, and reliable

bleed control with SEVENFACT 225 †

Rapid effect: 3 hour

At 3 hours, 84% of mild/moderate bleeding episodes were controlled
with a single dose

Predictable response: 84%
‡
At 9 hours, 84% of mild/moderate bleeding episodes treated achieved
bleed control after a single dose

Reliable control: 99.5%

At 24 hours, 99.5% of mild/moderate bleeding episodes were resolved

Convenient home use: 98%

98% of bleeding episodes were treated at home

† 225 mcg/kg initial dosing regimen in the clinical trial.
‡ As seen in the clinical trial.

1/20/21 12:44 PM
HEMA-1744 SevFact_PAT_sprdJA_HFA_dateline_FINAL.indd 1 1/20/21 12:44 PM
HEMA-1744 SevFact_PAT_sprdJA_HFA_dateline_FINAL.indd 1